Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Prinz

Showing results (161-170 of 187) with videos related to

Pageof 19
Sort By:
Journal of Dermatological Science|June 10, 2015
Leukocyte-derived koebnerisin (S100A15) and psoriasin (S100A7) are systemic mediators of inflammation in psoriasisAleksandra Batycka-Baran, Eva Hattinger, Stephanie Zwicker, et al.
Journal of the American Academy of Dermatology|September 21, 2011
Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trialsMark Lebwohl, Craig Leonardi, Christopher E M Griffiths, et al.
Endoscopy|June 28, 2006
Argon plasma ablation of gastric inlet patches in the cervical esophagus may alleviate globus sensation: a pilot trialA Meining, M Bajbouj, M Preeg, et al.
International Journal of Sports Medicine|September 14, 2012
Left ventricular mass and oxygen uptake in top handball athletesF van Buuren, K P Mellwig, T Butz, et al.
Clinical Hemorheology and Microcirculation|August 3, 2010
Microcirculation of subepithelial gastric tumors using contrast-enhanced ultrasoundK Stock, C Hann von Weyhern, J Slotta-Huspenina, et al.
Digestion|July 3, 2008
Do we need gastric acid?D Pohl, M Fox, M Fried, et al.
Annals of Neurology|June 29, 2016
CTLA4 as Immunological Checkpoint in the Development of Multiple SclerosisLisa Ann Gerdes, Kathrin Held, Eduardo Beltrán, et al.
The British Journal of Dermatology|October 14, 2014
Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-upR G Langley, M Lebwohl, G G Krueger, et al.
The British Journal of Dermatology|July 13, 2021
Lesional activation of T<sub>c</sub> 17 cells in Behçet disease and psoriasis supports HLA class I-mediated autoimmune responsesS Vural, K Kerl, P Ertop Doğan, et al.
The Journal of Investigative Dermatology|May 7, 2010
Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditionsBatya B Davidovici, Naveed Sattar, Jörg C Prinz, et al.
Pageof 19

Showing results (161-170 of 187) with videos related to

Sort By:
Pageof 19
Journal of Dermatological Science|June 10, 2015
Leukocyte-derived koebnerisin (S100A15) and psoriasin (S100A7) are systemic mediators of inflammation in psoriasisAleksandra Batycka-Baran, Eva Hattinger, Stephanie Zwicker, et al.
Journal of the American Academy of Dermatology|September 21, 2011
Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trialsMark Lebwohl, Craig Leonardi, Christopher E M Griffiths, et al.
Endoscopy|June 28, 2006
Argon plasma ablation of gastric inlet patches in the cervical esophagus may alleviate globus sensation: a pilot trialA Meining, M Bajbouj, M Preeg, et al.
International Journal of Sports Medicine|September 14, 2012
Left ventricular mass and oxygen uptake in top handball athletesF van Buuren, K P Mellwig, T Butz, et al.
Clinical Hemorheology and Microcirculation|August 3, 2010
Microcirculation of subepithelial gastric tumors using contrast-enhanced ultrasoundK Stock, C Hann von Weyhern, J Slotta-Huspenina, et al.
Digestion|July 3, 2008
Do we need gastric acid?D Pohl, M Fox, M Fried, et al.
Annals of Neurology|June 29, 2016
CTLA4 as Immunological Checkpoint in the Development of Multiple SclerosisLisa Ann Gerdes, Kathrin Held, Eduardo Beltrán, et al.
The British Journal of Dermatology|October 14, 2014
Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-upR G Langley, M Lebwohl, G G Krueger, et al.
The British Journal of Dermatology|July 13, 2021
Lesional activation of T<sub>c</sub> 17 cells in Behçet disease and psoriasis supports HLA class I-mediated autoimmune responsesS Vural, K Kerl, P Ertop Doğan, et al.
The Journal of Investigative Dermatology|May 7, 2010
Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditionsBatya B Davidovici, Naveed Sattar, Jörg C Prinz, et al.
Pageof 19